232 related articles for article (PubMed ID: 26492321)
1. Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging.
Romero E; Martínez A; Oteo M; García A; Morcillo MA
Appl Radiat Isot; 2016 Jan; 107():113-120. PubMed ID: 26492321
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
[TBL] [Abstract][Full Text] [Related]
3. Full automation of (68)Ga labelling of DOTA-peptides including cation exchange prepurification.
Ocak M; Antretter M; Knopp R; Kunkel F; Petrik M; Bergisadi N; Decristoforo C
Appl Radiat Isot; 2010 Feb; 68(2):297-302. PubMed ID: 19906533
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-labelled DOTA-derivatised peptide ligands.
Meyer GJ; Mäcke H; Schuhmacher J; Knapp WH; Hofmann M
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1097-104. PubMed ID: 15029459
[TBL] [Abstract][Full Text] [Related]
5. 68Ga 'vacuum elution approach' for direct radiolabelling of DOTA-conjugated and NODAGA-conjugated peptides.
Ben Azzouna R; Leygnac S; Al-Shoukr F; Rouzet F; Guilloteau D; Le Guludec D
Nucl Med Commun; 2017 Jan; 38(1):51-56. PubMed ID: 27824725
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and availability of ⁶⁸Ga-labelled peptides.
Decristoforo C; Pickett RD; Verbruggen A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S31-40. PubMed ID: 22388621
[TBL] [Abstract][Full Text] [Related]
7. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
8. Rapid and automated production of [
Tieu W; Hollis CA; Kuan KKW; Takhar P; Stuckings M; Spooner N; Malinconico M
Nucl Med Biol; 2019; 74-75():12-18. PubMed ID: 31421441
[TBL] [Abstract][Full Text] [Related]
9. Taking cyclotron
Nelson BJB; Wilson J; Richter S; Duke MJM; Wuest M; Wuest F
Nucl Med Biol; 2020; 80-81():24-31. PubMed ID: 32004935
[TBL] [Abstract][Full Text] [Related]
10. ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.
Ambrosini V; Campana D; Tomassetti P; Fanti S
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S52-60. PubMed ID: 22388622
[TBL] [Abstract][Full Text] [Related]
11. A methodical 68Ga-labelling study of DO2A-(butyl-L-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling.
Riss PJ; Burchardt C; Roesch F
Contrast Media Mol Imaging; 2011; 6(6):492-8. PubMed ID: 22144027
[TBL] [Abstract][Full Text] [Related]
12. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
[TBL] [Abstract][Full Text] [Related]
13. Production and purification of gallium-66 for preparation of tumor-targeting radiopharmaceuticals.
Lewis MR; Reichert DE; Laforest R; Margenau WH; Shefer RE; Klinkowstein RE; Hughey BJ; Welch MJ
Nucl Med Biol; 2002 Aug; 29(6):701-6. PubMed ID: 12234596
[TBL] [Abstract][Full Text] [Related]
14. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
[TBL] [Abstract][Full Text] [Related]
15. Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC.
Asti M; De Pietri G; Fraternali A; Grassi E; Sghedoni R; Fioroni F; Roesch F; Versari A; Salvo D
Nucl Med Biol; 2008 Aug; 35(6):721-4. PubMed ID: 18678358
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study.
Naswa N; Sharma P; Nazar AH; Agarwal KK; Kumar R; Ammini AC; Malhotra A; Bal C
Eur Radiol; 2012 Mar; 22(3):710-9. PubMed ID: 21971823
[TBL] [Abstract][Full Text] [Related]
17. Processing of generator-produced 68Ga for medical application.
Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
[TBL] [Abstract][Full Text] [Related]
18. Clinical indications for Gallium-68 positron emission tomography imaging.
Khan MU; Khan S; El-Refaie S; Win Z; Rubello D; Al-Nahhas A
Eur J Surg Oncol; 2009 Jun; 35(6):561-7. PubMed ID: 19201567
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B
Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519
[TBL] [Abstract][Full Text] [Related]
20. Automation synthesis modules review.
Boschi S; Lodi F; Malizia C; Cicoria G; Marengo M
Appl Radiat Isot; 2013 Jun; 76():38-45. PubMed ID: 23084477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
